The outcomes of Perthes' disease of the hip: a study protocol for the development of a core outcome set

被引:9
|
作者
Leo, Donato Giuseppe [1 ]
Leong, Wei Yee [2 ]
Gambling, Tina [3 ]
Long, Andrew [4 ]
Murphy, Rebecca [1 ]
Jones, Helen [1 ]
Perry, Daniel Christopher [5 ]
机构
[1] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England
[2] Alder Hey Childrens Hosp, Prescott Rd, Liverpool L14 2AB, Merseyside, England
[3] Cardiff Univ, Sch Healthcare Sci, Cardiff, S Glam, Wales
[4] Univ Leeds, Sch Healthcare, Leeds, W Yorkshire, England
[5] Univ Liverpool, Inst Translat Med, Inst Pk,Prescott Rd, Liverpool L14 2AB, Merseyside, England
关键词
Core outcomes set; Delphi; Consensus outcomes; Perthes' disease; Legg-calve-Perthes' disease;
D O I
10.1186/s13063-018-2695-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Perthes' disease is an idiopathic osteonecrosis of a developmental hip that is most frequent in Northern Europe. Currently, the absence of a common set of standardised outcomes makes comparisons between studies of different interventions challenging. This study aims to summarise the outcomes used in clinical research of interventions for Perthes' disease and define a set of core outcomes (COS) to ensure that the variables of primary importance are measured and reported in future research studies investigating Perthes' disease. Methods: A systematic review of the current literature will be used to identify a list of outcomes reported in previous studies. Additional important outcomes will be sought by interviewing a group of children with Perthes' disease, adults who were treated with the disease in infancy and parents of children with the disease. This list will then be evaluated by experts in Perthes' disease using a Delphi survey divided into two rounds to ascertain the importance of each outcome. The final outcomes list obtained from the Delphi survey will be then discussed during a consensus meeting of representative key stakeholders in order to define the COS to be reported in future clinical trials related to Perthes' disease. Discussion: The absence of high-quality research and clear guidelines concerning the management of Perthes' disease is, at least in part, due to the difficulties in the comparing the results from previous studies. The development of a COS seeks to standardise outcomes collected in future research studies to enable comparisons between studies to be made and to facilitate meta-analyses of results.
引用
收藏
页数:7
相关论文
共 50 条
  • [11] Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey
    Sanjana Iyengar
    Paula R. Williamson
    Jochen Schmitt
    Lena Johannsen
    Ian A. Maher
    Joseph F. Sobanko
    Todd V. Cartee
    Daniel Schlessinger
    Emily Poon
    Murad Alam
    Trials, 17
  • [12] Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey
    Iyengar, Sanjana
    Williamson, Paula R.
    Schmitt, Jochen
    Johannsen, Lena
    Maher, Ian A.
    Sobanko, Joseph F.
    Cartee, Todd V.
    Schlessinger, Daniel
    Poon, Emily
    Alam, Murad
    TRIALS, 2016, 17
  • [13] Development of an international Core Outcome Set (COS) for best care for the dying person: study protocol
    Sofia C. Zambrano
    Dagny Faksvåg Haugen
    Agnes van der Heide
    Vilma A. Tripodoro
    John Ellershaw
    Carl Johan Fürst
    Raymond Voltz
    Stephen Mason
    María L. Daud
    Gustavo De Simone
    Kerstin Kremeike
    Svandis Iris Halfdanardottir
    Valgerdur Sigurdardottir
    Jeremy Johnson
    Simon Allan
    Haroon Hafeez
    Catarina Simões
    Katrin Ruth Sigurdardottir
    Birgit H. Rasmussen
    Paula Williamson
    Steffen Eychmüller
    BMC Palliative Care, 19
  • [14] Development of an international core outcome set for treatment trials in necrotizing enterocolitis-a study protocol
    Klerk, Daphne H. H.
    van Varsseveld, Otis C. C.
    Offringa, Martin
    Modi, Neena
    Lacher, Martin
    Zani, Augusto
    Pakarinen, Mikko P. P.
    Koivusalo, Antti
    Jester, Ingo
    Spruce, Marie
    Derikx, Joep P. M.
    Bakx, Roel
    Ksia, Amine
    Vermeulen, Marijn J. J.
    Kooi, Elisabeth M. W.
    Hulscher, Jan B. F.
    TRIALS, 2023, 24 (01)
  • [15] Development of an international Core Outcome Set (COS) for best care for the dying person: study protocol
    Zambrano, Sofia C.
    Haugen, Dagny Faksvag
    van der Heide, Agnes
    Tripodoro, Vilma A.
    Ellershaw, John
    Furst, Carl Johan
    Voltz, Raymond
    Mason, Stephen
    Daud, Maria L.
    De Simone, Gustavo
    Kremeike, Kerstin
    Halfdanardottir, Svandis Iris
    Sigurdardottir, Valgerdur
    Johnson, Jeremy
    Allan, Simon
    Hafeez, Haroon
    Simoes, Catarina
    Sigurdardottir, Katrin Ruth
    Rasmussen, Birgit H.
    Williamson, Paula
    Eychmuller, Steffen
    BMC PALLIATIVE CARE, 2020, 19 (01)
  • [16] Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey
    Daniel I. Schlessinger
    Sanjana Iyengar
    Arianna F. Yanes
    Jill K. Henley
    Hovik J. Ashchyan
    Anastasia O. Kurta
    Payal M. Patel
    Umar A. Sheikh
    Matthew J. Franklin
    Courtney C. Hanna
    Brian R. Chen
    Sarah G. Chiren
    Jochen Schmitt
    Stefanie Deckert
    Karina C. Furlan
    Emily Poon
    Ian A. Maher
    Todd V. Cartee
    Joseph F. Sobanko
    Murad Alam
    Trials, 18
  • [17] Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey
    Schlessinger, Daniel I.
    Iyengar, Sanjana
    Yanes, Arianna F.
    Henley, Jill K.
    Ashchyan, Hovik J.
    Kurta, Anastasia O.
    Patel, Payal M.
    Sheikh, Umar A.
    Franklin, Matthew J.
    Hanna, Courtney C.
    Chen, Brian R.
    Chiren, Sarah G.
    Schmitt, Jochen
    Deckert, Stefanie
    Furlan, Karina C.
    Poon, Emily
    Maher, Ian A.
    Cartee, Todd V.
    Sobanko, Joseph F.
    Alam, Murad
    TRIALS, 2017, 18
  • [18] Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey
    Daniel I. Schlessinger
    Sanjana Iyengar
    Arianna F. Yanes
    Jake M. Lazaroff
    Victoria Godinez-Puig
    Brian R. Chen
    Anastasia O. Kurta
    Jill K. Henley
    Sarah G. Chiren
    Karina C. Furlan
    Jochen Schmitt
    Stefanie Deckert
    Emily Poon
    Joseph F. Sobanko
    Todd V. Cartee
    Murad Alam
    Ian A. Maher
    Trials, 18
  • [19] Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey
    Schlessinger, Daniel I.
    Iyengar, Sanjana
    Yanes, Arianna F.
    Lazaroff, Jake M.
    Godinez-Puig, Victoria
    Chen, Brian R.
    Kurta, Anastasia O.
    Henley, Jill K.
    Chiren, Sarah G.
    Furlan, Karina C.
    Schmitt, Jochen
    Deckert, Stefanie
    Poon, Emily
    Sobanko, Joseph F.
    Cartee, Todd V.
    Alam, Murad
    Maher, Ian A.
    TRIALS, 2017, 18
  • [20] Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey
    Schlessinger, Daniel I.
    Iyengar, Sanjana
    Yanes, Arianna F.
    Chiren, Sarah G.
    Godinez-Puig, Victoria
    Chen, Brian R.
    Kurta, Anastasia O.
    Schmitt, Jochen
    Deckert, Stefanie
    Furlan, Karina C.
    Poon, Emily
    Cartee, Todd V.
    Maher, Ian A.
    Alam, Murad
    Sobanko, Joseph F.
    TRIALS, 2017, 18